Medicare Patients Face High Out-of-Pocket Costs for Specialty Inflammatory Bowel Disease Medications.
Dong, Jeffrey, Michelle Ladonne, and Joseph D Feuerstein. 2023. “Medicare Patients Face High Out-of-Pocket Costs for Specialty Inflammatory Bowel Disease Medications.”. The American Journal of Gastroenterology 118 (3): 481-84.